Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Aprea Therapeutics, Inc. (APRE) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $28.71 Metrics
OS: 21.1 M
Market cap: $604 M
Net cash: $123 M $5.82 per share
EV: $482 M

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-19Dec-31-18Dec-31-17
Revenues0.00.00.0
Cost of goods sold0.00.00.0
Gross profit0.00.00.0
Research and development21.014.213.4
General and administrative8.62.32.5
EBIT-28.4-15.5-15.2
Pre-tax income-28.1-15.5-15.2
Income taxes0.00.00.0
            Tax rate0.0%0.0%0.0%
Net income-28.1-15.5-15.2
 
Diluted EPS($4.67)($13.45)($13.17)
Shares outstanding (diluted)6.01.21.2
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy